Common virus jab could be key in fight against multiple sclerosis
The vaccine will be trialled in patients recently diagnosed with MS

© PA Wire
The vaccine will be trialled in patients recently diagnosed with MS

© PA Wire
Steve Browne, 59, was diagnosed with bowel cancer in 2012, aged 45
.jpg?width=1200&auto=webp&trim=122%2C0%2C197%2C0)
© Steve Browne
Cancer Research UK surveyed 6,844 people to understand what prevented people from getting help
.jpg?width=1200&auto=webp&trim=122%2C0%2C197%2C0)
© Steve Browne
UPFs have been linked to poor health, including an increased risk of obesity, heart disease, cancer and early death

© Alamy/PA
A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could offer a novel treatment pathway for multiple sclerosis (MS).

© PA Wire